+ Filter
Loading...
WSX receptor
Anti-WSX receptor Recombinant Antibody Products
- Human Anti-WSX receptor Recombinant Antibody (clone #3) (HPAB-S0153-YC)
-
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, Agonist
Compare
- Human Anti-WSX receptor Recombinant Antibody (clone #4) (HPAB-S0154-YC)
-
- Species Reactivity: Human, Mouse
- Type: Human IgG
- Application: ELISA, Agonist
Compare
- Human Anti-WSX receptor Recombinant Antibody (clone #17) (HPAB-S0155-YC)
-
- Species Reactivity: Human, Mouse
- Type: Human IgG
- Application: ELISA, Agonist
Compare
- Human Anti-WSX receptor Recombinant Antibody (clone #17); Fab Fragment (HPAB-S0155-YC-F(E))
-
- Species Reactivity: Human, Mouse
- Type: Human Fab
- Application: ELISA, Agonist
Compare
- Human Anti-WSX receptor Recombinant Antibody (clone #17); scFv Fragment (HPAB-S0155-YC-S(P))
-
- Species Reactivity: Human, Mouse
- Type: Human scFv
- Application: ELISA, Agonist
Compare
- Human Anti-WSX receptor Recombinant Antibody (clone #4); Fab Fragment (HPAB-S0154-YC-F(E))
-
- Species Reactivity: Human, Mouse
- Type: Human Fab
- Application: ELISA, Agonist
Compare
- Human Anti-WSX receptor Recombinant Antibody (clone #4); scFv Fragment (HPAB-S0154-YC-S(P))
-
- Species Reactivity: Human, Mouse
- Type: Human scFv
- Application: ELISA, Agonist
Compare
- Human Anti-WSX receptor Recombinant Antibody (clone #3); Fab Fragment (HPAB-S0153-YC-F(E))
-
- Species Reactivity: Human
- Type: Human Fab
- Application: ELISA, Agonist
Compare
- Human Anti-WSX receptor Recombinant Antibody (clone #3); scFv Fragment (HPAB-S0153-YC-S(P))
-
- Species Reactivity: Human
- Type: Human scFv
- Application: ELISA, Agonist
Compare
More Infomation
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
WSX receptor or WSX ligand antagonists (such as WSX receptor ECD or immunoadhesin, and WSX receptor or OB protein neutralizing antibodies) may be used in the treatment of those disorders wherein unacceptable lymphocyte levels are present in the mammal, particularly where this is caused by excessive activation of the WSX receptor. Examples of conditions in which administration of such an antagonist may be beneficial include: neoplastic disorders (such as Hodkin's disease; lymphosarcoma; lymphoblastoma; lymphocytic leukemia; and lymphoma) and lymphocytosis.